OPKO Health Q2 2026 earnings preview shows consensus estimates of -$0.08 EPS and $131.23M revenue

Earnings
โดย Seeking Alpha·Read original
Summary · why it matters

OPKO Health is scheduled to announce its second-quarter 2026 earnings results on Monday, July 27th, after market close. The consensus EPS estimate stands at -$0.08, while the consensus revenue estimate is $131.23 million, representing a 16.3% decline year-over-year. The company previously outlined Q2 2026 revenue guidance in the range of $127 million to $132 million as its ModeX unit advances five clinical programs.

Impact on stocks 1

Biotech & Genomic Medicine · 1 stocks
Opko Health Inc
OPK
± MixedCapitalrelevance

Earnings preview with consensus estimates and revenue guidance, but actual results not yet released.